INNOVA CAPTAB
Back to Cashflow Statement
|
INNOVA CAPTAB Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹64 Cr | ₹146 Cr | ₹67 Cr | ₹59 Cr | ₹42 Cr |
What is the latest Cash Flow from Operating Activities ratio of INNOVA CAPTAB ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹64 Cr |
| Mar2024 | ₹146 Cr |
| Mar2023 | ₹67 Cr |
| Mar2022 | ₹59 Cr |
| Mar2021 | ₹42 Cr |
How is Cash Flow from Operating Activities of INNOVA CAPTAB Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹64 Cr | -56.37 | |
| Mar2024 | ₹146 Cr | 118.01 | |
| Mar2023 | ₹67 Cr | 13.97 | |
| Mar2022 | ₹59 Cr | 41.70 | |
| Mar2021 | ₹42 Cr | - | |
Compare Cash Flow from Operating Activities of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹4,118.7 Cr | 4.3% | -1.3% | -29.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,131.0 Cr | -0.7% | -0.5% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,862.0 Cr | 2.9% | 1.8% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,254.0 Cr | 1.5% | 3.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹121,198.0 Cr | 0.2% | -0.2% | 0.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,083.0 Cr | 0.9% | 4.8% | -3.2% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | 4.3% |
-1.3% |
-29.3% |
| SENSEX | 1% |
0.3% |
6.7% |
You may also like the below Video Courses